ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
Spheroid-based matrix-induced autologous chondrocyte implantation combined with autologous bone grafting restores physiological cartilage and subchondral bone properties in osteochondral knee defects-An MRI-based analysis.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the radiological and patient-reported outcome measures (PROMs) following spheroid-based matrix-induced autologous chondrocyte implantation combined with autologous bone grafting (MABCI) for the treatment of osteochondral defects of the knee.
methodsIn this retrospective cohort analysis of prospectively collected data, 28 consecutive patients with 29 defects of the femoral condyle (male: 15, female: 13, mean age 27.3 ± 9.8 years, mean defect size 3.7 ± 1.6 cm²) treated with MABCI were included. Radiological assessments were performed using 3T magnetic resonance imaging (MRI) to evaluate cartilage thickness, T2 relaxation times and Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) 2.0 scores. Clinical outcomes were assessed using validated PROMs, including the International Knee Documentation Committee (IKDC) score, the Knee Injury and Osteoarthritis Outcome Score (KOOS), the Lysholm scale and the Patient-Reported Outcomes Measurement Information System 29-Item Profile (PROMIS-29). Correlation analyses were conducted to evaluate associations between radiological parameters and PROMs.
resultsThe analysis was conducted at a mean follow-up of 44.4 ± 21.6 months. Cartilage thickness in the repair tissue exceeded that of the reference cartilage (3.4 ± 0.9 mm vs. 3.0 ± 0.5 mm; p = 0.036), while T2 relaxation times in the repair tissue were within physiological range (50.5 ± 40.0 ms vs. 41.3 ± 5.4 ms; n.s.). The mean MOCART 2.0 score was 61.3 ± 13.0 (volume fill: 16.1 ± 3.7, integration with adjacent cartilage: 12.9 ± 3.3), reflecting satisfactory repair quality. All clinical scores showed significant improvement compared to the preoperative condition (IKDC: 70.6 ± 13.2 vs. 54.8 ± 17.5, p < 0.001; KOOS: pain 78.7 ± 16.9 vs. 66.1 ± 18.6, p = 0.002, symptoms 75.6 ± 16.0 vs. 65.8 ± 19.1, p = 0.006, ADL 86.8 ± 14.0 vs. 77.6 ± 16.8, p = 0.003, sport 63.0 ± 24.2 vs. 47.3 ± 26.9, p = 0.009, quality of life (QoL) 51.0 ± 22.7 vs. 39.6 ± 17.5, p = 0.014; numeric pain rating scale: 3.0 ± 2.2 vs. 5.2 ± 2.4, p < 0.001). A greater cartilage thickness was associated with reduced pain intensity (r = -0.457, p = 0.013) and improved QoL (r = 0.429, p = 0.020), indicating that better structural repair is associated with improved patient satisfaction.
conclusionsMABCI results in satisfactory cartilage regeneration and subchondral remodelling in addition to significant improvements in patient satisfaction and overall QoL. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.